Questions to Ask Before Prostate Artery Embolization

In short: Before prostate artery embolization, ask what shows BPH is causing your symptoms, whether more urologic testing is needed, whether you are a reasonable candidate, what improvement is realistic, how PAE compares with the alternatives, which risks apply to you, the physician’s PAE experience, what recovery involves, how results will be measured, and what happens if PAE is not enough. Dr. Nathanael Sabbah, interventional radiologist at SoCal Interventional, answers these at consultations in Van Nuys, Tarzana and Fountain Valley.

Editorially updated July 20, 2026. Prepared by SoCal Interventional using the clinical sources listed below. This checklist is educational and cannot determine whether PAE is appropriate for an individual patient.

A productive prostate artery embolization consultation should do more than confirm that the procedure is minimally invasive. It should clarify the diagnosis, realistic benefit, possible harms, alternatives, physician experience, and follow-up plan.

Bring your medication list, relevant laboratory results, prostate imaging, urology records, prior procedure reports, and a written list of priorities. The following questions can help patients compare PAE with other BPH treatments.

1. What shows that BPH is causing my symptoms?

Urinary symptoms can result from prostate obstruction, bladder dysfunction, infection, medication effects, urethral narrowing, neurologic disease, or other conditions. Ask which findings support BPH and whether important alternatives have been evaluated.

2. Do I need additional urologic testing?

Depending on the history, clinicians may consider urinalysis, prostate-specific antigen testing, postvoid residual measurement, urinary-flow testing, ultrasound or MRI, cystoscopy, or urodynamics. Ask whether cancer evaluation is current and whether a urology opinion would change the decision.

3. Am I a reasonable PAE candidate?

A reasonable PAE candidate typically has bothersome urinary symptoms confirmed to come from BPH, a prostate whose size and arterial anatomy allow embolization, adequate kidney function, and no active infection or unresolved concern about prostate cancer. Blood thinners, contrast allergy and bladder function change the plan rather than always excluding it. Candidacy is confirmed at an in-person evaluation.

Ask how symptom severity, prostate anatomy, arterial disease, kidney function, contrast allergy, anticoagulants, infection risk, urinary retention, and bladder function affect candidacy. Review the full PAE candidacy guide.

4. What improvement is realistic for me?

Realistic improvement after PAE is a gradual, meaningful reduction in urinary symptoms over weeks to months, on average somewhat smaller than after TURP: in a five-year randomized trial both groups improved, but TURP did better on several outcomes. Which symptoms respond, and by how much, varies from man to man.

Request a personalized discussion rather than a universal success percentage. Ask which symptoms are likely to respond, how response will be measured, how long improvement may take, and what would count as an inadequate result.

A five-year randomized trial found improvement after both PAE and TURP, with greater improvement in several outcomes after TURP. That tradeoff is relevant when choosing between less invasive access and the degree of expected urinary improvement.

5. How does PAE compare with my alternatives?

Ask specifically about observation, medication, TURP, HoLEP, aquablation, water-vapor therapy, prostatic urethral lift, and any option recommended for your prostate size and anatomy. Compare anesthesia, catheter use, recovery, urinary-flow improvement, sexual effects, durability, and retreatment.

The AUA BPH guideline emphasizes shared decision-making because no procedure has the same balance of benefits and harms for every patient.

6. What PAE risks are most relevant to me?

Discuss access-site bleeding or bruising, infection, temporary urinary or pelvic symptoms, acute retention, contrast reaction, kidney injury, radiation, and rare non-target embolization. Ask which risks are increased by your medical history and how the team works to reduce them.

7. What is your PAE training and experience?

Reasonable questions include how often the physician performs PAE, how arterial anatomy is planned, how non-target vessels are protected, how technical difficulty is handled, what setting is used for the procedure, and how complications are managed. Learn about Dr. Nathanael Sabbah’s stated training and clinical roles. For a detailed explanation of specialties and qualifications, read what type of doctor performs prostate artery embolization.

8. What should I expect during recovery?

Recovery after PAE is usually measured in days for routine activity: expect access-site soreness, several days of pelvic discomfort, mild urinary burning and sometimes a low-grade fever, with urinary improvement building over weeks to months. Most men go home the same day and usually need no catheter, but a fixed return-to-work date cannot be promised.

Ask about access-site care, prescribed medicines, temporary urinary symptoms, driving, exercise, work, hydration, constipation prevention, catheter management if relevant, and the symptoms that require urgent contact. Recovery varies; a fixed return-to-work promise is not appropriate.

9. How will we measure the result?

Follow-up may include a symptom score, medication use, ability to urinate, postvoid residual, urinary flow, and patient-defined goals. Ask when follow-up occurs and which team—interventional radiology, urology, or primary care—will handle each part.

10. What happens if PAE does not help enough?

If PAE does not help enough, the options are the same as before: continued or adjusted medication, a repeat embolization when the arteries can still be reached, or a urologic procedure such as TURP or HoLEP. A prior PAE generally does not prevent later surgery, and the plan should be coordinated between interventional radiology and urology.

Clarify whether repeat imaging, continued medication, repeat embolization, or a surgical treatment would be considered. PAE generally does not prevent later urologic treatment, but future care should be coordinated.

Sources

• AUA BPH guideline
• SIR: Multisociety PAE position statement
• Five-year randomized PAE versus TURP trial
• SoCal Interventional medical editorial policy

To request a PAE consultation, review location-specific information for Fountain Valley, Tarzana, or Van Nuys, or call (310) 929-0026.